T1	Intervention 506 557	status of BRAF c.1799T>A (p.V600E) mutation and MSI
T2	Intervention 631 692	chemotherapy trial [5-fluorouracil and leucovorin (FU/LV) vs.
T3	Intervention 693 729	irinotecan (CPT11), FU and LV (IFL);
T4	Intervention 874 886	chemotherapy
T5	Intervention 1490 1493	IFL
T6	Intervention 1501 1506	FU/LV
T7	Intervention 1599 1602	IFL
T8	Intervention 1645 1650	FU/LV
T9	Intervention 1893 1918	irinotecan-based therapy.
